Mar 1, 2026 Log in

News

WAKANSE (1783) March 2026 Revenue: 70 Million Yen (Year-on-Year +0.1%)

Citation-Grade Primary-source linked Schema.org verified NQ 4 / 100

Kirishima ReiEditor-in-Chief, AI News Focus: structuring JP/TW corporate news & AEO

Published Mar 1, 2026 9:00 AM ・ Updated Jun 1, 2026 1:10 PM ・ 2 min read ・ Source: PR Times

Show contents

⚡ Key Points

The company operates in the biotechnology and healthcare industry.

WAKANSE announced its revenue for March 2026, reaching 69.939 million yen (approximately 0.70 hundred million yen), a slight increase of 0.1% compared to the same period last year. The company operates in the biotechnology and healthcare industry.

PRIMARY SOURCE Original source: https://openapi.twse.com.tw/revenue/twse-rev-1783-11503 Distributor: PR Times
Published: Mar 1, 2026

Company Code: 1783 Company Name: WAKANSE Industry: Biotechnology and Healthcare Data Month: 2026-03 Monthly Revenue: 69,939 thousand yen (0.70 hundred million yen) Year-on-Year Change (Same Month Last Year): +0.1%

FACT BOX

Source: PR Times
Category: News
Dates in source: 2026-03

Editorial & Verification Standards

The Washin AI News desk structures and reviews this article under the following standards.

Start only from primary sources (official PR, disclosures, wire services)
Numbers and proper nouns machine-checked against the source (number-completeness check)
Company names and tickers verified via registry (Registry/TWSE/Wikidata)
No speculation; nothing stated that is not in the source

Read the full editorial policy →

Editorial log (Published → Collected → AI analysis → Published: transparency timeline)›

Announced　Mar 1, 2026 9:00 AM — Distributor PR Times
Collected　Apr 12, 2026 4:30 PM
AI structured & analyzed　Apr 12, 2026 5:27 PM
Desk-reviewed & published　Mar 1, 2026 9:00 AM

FAQ

What was WAKANSE's revenue for March 2026?

WAKANSE's monthly revenue for March 2026 was approximately 70 million yen (69.939 million yen).

How did the revenue compare to the same month last year?

It increased by 0.1% compared to the same month last year.

What kind of business does WAKANSE operate?

WAKANSE operates in the biotechnology and healthcare industry, developing and selling pharmaceuticals and medical devices.

Cite this article — HOW TO CITE

Washin AI News Desk“WAKANSE (1783) March 2026 Revenue: 70 Million Yen (Year-on-Year +0.1%)”AI News by Washin Village（和心村）, Mar 1, 2026. https://aeo.idaeo.ai/ai/%E5%92%8C%E5%BA%B7%E7%94%9F/en/news/2026-03-01-wakanse-1783-march-2026-revenue-70-milli

AI CRAWLER ACTIVITY

as of Aug 19, 2026

AI crawler visits to this article (cumulative)162 bots

Site-wide cumulative

Applebot

bot_visits_summary

2505k

last Aug 19, 2026

GPTBot

bot_visits_summary

1917k

last Aug 19, 2026

ClaudeBot

bot_visits_summary

1107k

last Aug 19, 2026

Bingbot

bot_visits_summary

662k

last Aug 19, 2026

Amazonbot

bot_visits_summary

656k

last Aug 19, 2026

Meta AI

bot_visits_summary

402k

last Aug 19, 2026

※ Only measured values from bot_visits_summary / crawler_url_hits are shown. Article-level zero counts are shown as measuring.

Washin AI News（AI News by Washin Village（和心村））

An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.

Daily
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification

About the publisher IDA llms.txt

Get your announcement indexed as AI-citable structured news.
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →

← 和康生 Back to newsroom (71)

Copied